Vis enkel innførsel

dc.contributor.advisorClaus, Klingenberg
dc.contributor.advisorNorbakken Granslo, Hildegunn
dc.contributor.authorHolmebukt, Synnøve
dc.contributor.authorGundersen, Oda Aspenes
dc.date.accessioned2024-07-05T11:18:13Z
dc.date.available2024-07-05T11:18:13Z
dc.date.issued2024-06-02
dc.description.abstractBackground: The Viridans group streptococci (VGS) is a common commensal bacterium and is historically counted as a contaminant when cultured in blood. Over the past years there seem to be an increase in the incidence of invasive VGS infections, especially in children and neutropenic patients. The knowledge about VGS as source of severe infections in children is limited. The purpose of this scoping review is to summarize data from current available literature on the antimicrobial resistance (AMR) profiles of VGS as cause of sepsis in neonates and children after the neonatal period. <p> <p>Method: A systematic literature search was performed in MEDLINE and Embase, and matching studies published between 1st of January 2015 – 31st of December 2023 were considered. We aimed to identify articles reporting VGS as cause of sepsis in children and neonates. After full text-screening all included studies also reporting AMR patterns for VGS were included in this sub-study. Two reviewers independently screened abstracts and full text articles. The study is registered in an international prospective register for systematic reviews (PROSPERO ID: CRD42022282804) but was later changed to a scoping review. <p> <p>Results: In total, 18 articles were included after screening 9219 abstracts and 1287 potentially relevant full text articles. In total, 194/776 (25%) isolates were resistant to penicillin, 92/276 (33.3%) isolates were resistant to ampicillin/amoxicillin, 14/29 (48.3%) isolates were resistant to gentamicin, 164/748 (21.9%) isolates were resistant to 3rd generation cephalosporines, 275/393 (70.0%) to erythromycin, 10/442 (2.3%) isolates were resistant to vancomycin and 57/565 (10.1%) were resistant to fluoroquinolones. <p> <p>Conclusion: In conclusion, the data showing antibiotic susceptibility patterns for VGS-bacteremia in children are still limited, and findings from existing literature are diverse. To examine this matter closer, we suggest more research on AMR in VGS.en_US
dc.identifier.urihttps://hdl.handle.net/10037/34090
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2024 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subject.courseIDMED-3950
dc.subjectsepsisen_US
dc.subjectbacteremiaen_US
dc.subjectneonateen_US
dc.subjectchilden_US
dc.subjectantimicrobial resistanceen_US
dc.subjectviridans group streptococien_US
dc.subjectimmunocompromiseden_US
dc.subjectneutropeniaen_US
dc.subjectblood cultureen_US
dc.titleViridans group streptococci (VGS) – antimicrobial resistance in children with sepsis. A scoping review.en_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)